We wish to inform you about the financial assistance of the participating companies according to their membership in FSA e.V. (Association for Voluntary Self-Control of the Pharmaceutical Industry), AKG e.V. (Association for Medicinal Products and Cooperation in the Health Sector) or because the companies have approved the publication.
Regardless of the above-mentioned memberships, the conditions and scope of financial assistance of all companies as well as specialist publishers who support the event will be published, if this is stipulated by the professional codes of the respective regional medical associations.
Moreover, this complies with the recommendations of the Federal Medical Association (Bundesärztekammer) on continuing medical education, 4th revised edition, last updated: 24 April 2015, p.11 et seq., section 32 para. (3) of the (Model) Professional Code for Physicians in Germany ((Muster-)Berufsordnung für die in Deutschland tätigen Ärztinnen und Ärzte – MBO), section 8 para. (1) no. 3 of the (Model) Continuing Medical Education Code (Musterfortbildungsordnung – MFO).
The content of this event is designed to be product- and service-neutral. We confirm that the scientific management and the speakers will disclose potential conflicts of interest to the participants. The following companies are sponsors:
Abbott Medical GmbH 4.000,00 EUR; Angiodroid SpA. 4.000,00 EUR; Artivion, Inc. JOTEC GmbH 12.000 EUR; Asanus Medizintechnik GmbH 4.000 EUR; BD Becton Dickinson GmbH 10.000,00 EUR; Bentley InnoMed GmbH 4.000,00 EUR; Boston Scientific Medizintechnik GmbH 12.000,00 EUR; Brainlab AG 4.000,00 EUR; Cook Deutschland GmbH 6.000,00 EUR; Cordis Germany GmbH 2.500,00 EUR; Endologix International Holdings B.V. 4.000,00 EUR; Getinge Deutschland GmbH 2.500,00 EUR; Inari Medical Europe GmbH 8.000,00 EUR; iThera Medical GmbH 4.000,00 EUR; Lamed GmbH 10.000,00 EUR; LeMaitre Vascular GmbH 4.000,00 EUR; Lombard Medical Technologies GmbH 9.000,00 EUR; Medistim Deutschland GmbH 12.000,00 EUR; Medtronic GmbH 25.000,00 EUR; NXT MED GmbH 4.000,00 EUR; Optimed Medizinische Instrumente GmbH 12.000,00 EUR; Penumbra Europe GmbH 8.000,00 EUR; Pfizer Pharma GmbH 4.000,00 EUR; shape memory medical 4.000,00 EUR; SHOCKWAVE MEDICAL INC 10.000,00 EUR; Siemens Healthineers AG 500,00 EUR; Terumo Deutschland GmbH 3.000,00 EUR; Vascutek Deutschland GmbH t/a Terumo Aortic 14.500,00 EUR; Veryan Medical limited 3.500,00 EUR; W. L. Gore & Associates GmbH 10.000,00 EUR; Ziehm Imaging GmbH 2.500,00 EUR.
The total expenses amount to 254.810,00 EUR.
